Viking Therapeutics, Inc.
VKTX
DELAYED 1 MONTH

5 insider filings · Latest: Jul 28, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jul 29, 2026Jul 30 12:07 AMBrian LianDirector, President & CEO
Sale
148,517$33.32$4.9M2,572,441(D)

View →

Jul 29, 2026Jul 30 12:06 AMGreg ZanteChief Financial Officer
Sale
21,217$33.47$710.1K212,204(D)

View →

Jul 29, 2026Jul 30 12:06 AMMarianna ManciniChief Operating Officer
Sale
18,217$33.47$609.6K422,760(D)

View →

Mar 10, 2026Mar 10 10:20 PMNeil William AubuchonChief Commercial Officer
Purchase
4,475$33.50$149.9K4,475(D)

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jun 1, 2026Jun 3 11:44 PMHubert C ChenChief Medical Officer
Grant/Award
190,000$31.27190,000(D)

View →